ArticleFrontiers in pharmacology2022

Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma.

Jing Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.